Esophagus Cancer Terminated Phase 2 Trials for Gimeracil (DB09257)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02216149Effects of S-1 and Capecitabine on Coronary Artery Blood FlowTreatment